Related Experiment Video

Updated: Aug 24, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

519

Complement use of Chinese herbal medicine after percutaneous coronary intervention: a prospective observational study

Si-Yu Yan1, Wei-Xian Yang1, Pei-Pei Lu1

  • 1Chinese Academy of Medical Sciences & Peking Union Medical College Fuwai Hospital, Xicheng District, Beijing, China.

Journal of Geriatric Cardiology : JGC
|October 26, 2022
PubMed

Insights

Chinese herbal medicine use after percutaneous coronary intervention (PCI) in coronary artery disease (CAD) patients was associated with a lower incidence of major adverse cardiovascular events (MACE). Further randomized studies are recommended to confirm these findings.

Area of Science:

  • Cardiovascular Medicine
  • Integrative Oncology
  • Pharmacology

Background:

  • Chinese herbal medicine is frequently used alongside conventional treatments for coronary artery disease (CAD) post-percutaneous coronary intervention (PCI).
  • This study investigated the impact of Chinese herbal medicine on major adverse cardiovascular events (MACE) in CAD patients after PCI.

Purpose of the Study:

  • To compare the incidence of MACE in CAD patients undergoing PCI, with and without the complementary use of Chinese herbal medicine.

Main Methods:

  • A prospective, observational study followed 5453 patients for two years post-PCI.
  • MACE (all-cause mortality, revascularization, myocardial infarction) was compared between patients using only Western medicine and those using Chinese herbal medicine adjunctively.
  • Unadjusted and risk-adjusted analyses (Kaplan-Meier, multivariable Cox regression) were performed.

Main Results:

  • The incidence of MACE was 15.3% in the Western medicine group and 11.54% in the integrative medicine group.
  • Cox regression analysis revealed a 27% lower cumulative incidence of MACE in patients using Chinese herbal medicine (HR=0.73, P<0.0001).

Conclusions:

  • Complementary use of Chinese herbal medicine in CAD patients after PCI is linked to reduced 2-year MACE incidence.
  • Further randomized controlled trials are necessary to establish definitive evidence of benefit.
Abstract

More Related Videos

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.4K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

275

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
16